#Synovialsarcoma
दुर्लभ कैंसर से हाथ कटने के बाद 22 साल की इन्फ्लुएंसर ने किया उसका अंतिम संस्कार'
#WorldCancerDay #Synovialsarcoma #EldiaraDoucett #cancersurvivor #Cancer #morningnews
February 4, 2025 at 4:00 AM
My #SynovialSarcoma diagnosis was 25 years ago next month, kicking off three years of radiation, surgeries, and chemo. Somehow, I got through. And it's all been dessert. I've made novels and photographs and friends. It was random luck mixed with amazing medical professionals, but I'll take it.
January 9, 2025 at 4:19 PM
Chemo round 3 yesterday for my #SynovialSarcoma. 6th time fighting this horrific disease. I'm so incredibly exhausted of having to do this. New clinical trial opens later this year so we're trying to keep me stable for that.
January 8, 2025 at 1:45 PM
Stanford has treated its 1st patient with Tecelra. Tecelra is the first FDA-approved engineered TCR therapy, specifically for #SynovialSarcoma. med.stanford.edu/cancer/about... @drbetofmdphd.bsky.social #Tcelltherapy
Stanford infuses first patient with innovative solid tumor therapy
Stanford treated its first patient with Tecelra, a breakthrough engineered T cell receptor therapy that uses a patient’s own immune cells to target cancer.
med.stanford.edu
April 3, 2025 at 4:02 PM
The first sign of #sarcoma isn't always obvious. Carol Haslam of Sarcoma Cancer Ireland said she noticed "a bit of an ache" in her hand. When she sought care, she was referred to a specialist who discovered she had #SynovialSarcoma.
#SarcomaAwarenessMonth2025
#SarcomaSignsAndSymptoms
#KnowYourNormal
July 3, 2025 at 2:21 PM
📰 NEW at #NatureMedicine! PRAME-specific TCR-expressing autologous T cells are safe & elicit durable responses in patients with r/r PRAME+ solid tumors, including #melanoma and #SynovialSarcoma @natureportfolio.nature.com #OncSky #immunotherapy www.nature.com/articles/s41...
Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial - Nature Medicine
In a non-prespecified interim analysis of a phase 1 trial, autologous PRAME-directed TCR T cell therapy was safe and elicited durable responses in patients with recurrent and/or treatment-refractory P...
www.nature.com
April 10, 2025 at 7:28 PM
Natasha Allen: 28-Year-Old TikToker Who Shared Her Cancer Journey Has Died: The online community is mourning the loss of Natasha Allen, a 28-year-old who passed away after a courageous fight with synovial sarcoma,…

The post… #CancerAwareness #TikTok #MentalHealth #SynovialSarcoma #InMemoriam
Natasha Allen: 28-Year-Old TikToker Who Shared Her Cancer Journey Has Died
The online community is mourning the loss of Natasha Allen, a 28-year-old who passed away after a courageous fight with synovial sarcoma,… The post Natasha Allen: 28-Year-Old TikToker Who Shared Her Cancer Journey Has Died appeared first on Shine My Crown.
dlvr.it
August 28, 2025 at 1:51 PM